We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

57 hedge funds and large institutions have $94.4M invested in Akebia Therapeutics in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $391K | Put options by funds: $107K

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

46% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 13

12% more funds holding

Funds holding: 51 → 57 (+6)

44% less capital invested

Capital invested by funds: $170M → $94.4M (-$75.4M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
57
Holders Change
+6
Holders Change %
+11.76%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
19
Reduced
13
Closed
8
Calls
$391K
Puts
$107K
Net Calls
+$284K
Net Calls Change
-$1.54M

Top Buyers

1
EAM
Eagle Asset Management
Florida
+$11.2M
2
BFA
BlackRock Fund Advisors
California
+$3.86M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.28M
4
Millennium Management
Millennium Management
New York
+$1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$964K

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$4.8M
2
CAM
Cormorant Asset Management
Massachusetts
-$4.04M
3
Jennison Associates
Jennison Associates
New York
-$3.97M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.95M
5
EAM
Eventide Asset Management
Massachusetts
-$3.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$17.7M – – –
EAM
2
Eagle Asset Management
Florida
$14.2M +$11.2M +783,610 +178%
Stifel Financial
3
Stifel Financial
Missouri
$11.6M -$1.43K -100 -0%
HM
4
HealthCor Management
New York
$9.84M -$785K -54,746 -6%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$8.43M -$3.95M -275,200 -28%
RCM
6
RA Capital Management
Massachusetts
$6.95M – – –
BFA
7
BlackRock Fund Advisors
California
$5.32M +$3.86M +268,909 +143%
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.69M +$964K +67,214 +41%
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$2.67M +$3.28M +228,934 New
Morgan Stanley
10
Morgan Stanley
New York
$1.44M -$2.57M -179,377 -59%
CAM
11
Cormorant Asset Management
Massachusetts
$1.37M -$4.04M -282,000 -71%
Millennium Management
12
Millennium Management
New York
$1.34M +$1M +69,941 +155%
State Street
13
State Street
Massachusetts
$1.14M +$336K +23,407 +31%
FWIA
14
Fort Washington Investment Advisors
Ohio
$1.09M -$229K -16,000 -15%
Franklin Resources
15
Franklin Resources
California
$1.01M -$4.8M -335,000 -79%
Northern Trust
16
Northern Trust
Illinois
$932K +$9.82K +685 +0.9%
CS
17
Candriam SCA
Luxembourg
$890K +$1.1M +76,485 New
BIT
18
BlackRock Institutional Trust
California
$868K +$7.4K +516 +0.7%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$469K +$61.4K +4,279 +12%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$406K +$69.7K +4,861 +16%
NFA
21
Nationwide Fund Advisors
Ohio
$399K +$406K +28,312 +474%
TCIM
22
TIAA CREF Investment Management
New York
$337K -$13K -905 -3%
BIM
23
BlackRock Investment Management
Delaware
$268K +$1.61K +112 +0.5%
Bank of America
24
Bank of America
North Carolina
$268K +$308K +21,448 +1,357%
CS
25
Credit Suisse
Switzerland
$229K +$282K +19,695 New
1
2 3

AKBA Hedge Fund Activity: Q4 2014 in Review

57 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q4 2014, worth a combined $94.4M — down 44% from $170M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AKBA positions and 8 closed out — a net gain of 8 holders — while 19 added to existing stakes and 13 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $11.2M. The largest seller was Franklin Resources, cutting an estimated $4.8M.

  • 57 institutional investors held Akebia Therapeutics (AKBA) as of Q4 2014, up from 51 in Q3 2014.
  • Funds reported $94.4M of Akebia Therapeutics stock for Q4 2014, down 44% quarter-over-quarter.
  • 16 funds opened new Akebia Therapeutics positions in Q4 2014 and 8 closed out, a net change of +8 holders.
  • The largest Akebia Therapeutics buyer in Q4 2014 was Eagle Asset Management, an estimated $11.2M added.
  • The largest Akebia Therapeutics seller in Q4 2014 was Franklin Resources, an estimated $4.8M sold.

Based on aggregated 13F filings for Q4 2014.